Israel Biotech Fund

Researcher
By  Laura Lovett 02:05 pm February 18, 2022
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.  However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...